Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/9746

Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Title: Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.
Authors : Pastor, Myriam
Fernández Calle, Rosalía
Di Geronimo Quintero, Bruno
Vicente Rodríguez, Marta
Zapico Rodríguez, José María
Gramage Caro, Esther
Coderch Boué, Claire
Pérez García, Carmen
Lasek, Amy W.
Puchades-Carrasco, Leonor
Pineda-Lucena, Antonio
Pascual-Teresa Fernández, Beatriz de
Herradón Gil-Gallardo, Gonzalo
Ramos González, Ana
Keywords: PTPRZ1inhibitorsPleiotrophinNeurogenerative diseases
Publisher: Elsevier
Citation: Pastor M, Fernández-Calle R, Di Geronimo B, Vicente-Rodríguez M, Zapico JM, Gramage E, et al. Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. Vol. 144, European Journal of Medicinal Chemistry. 2018. p. 318-29
URI: http://hdl.handle.net/10637/9746
Rights : http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
ISSN: 0223-5234
Issue Date: 20-Jan-2018
Center : Universidad San Pablo-CEU
Appears in Collections:Facultad de Farmacia





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.